Mutations inPJVK cause autosomal recessive hearing loss (DFNB59), and Pejvakin modulates actin dynamics to sustain OHC activity and survival in a cell-autonomous manner, which may depend on its interaction with ROCK2 and other Rho effectors[42]. The gene discussed is ROCK2; the disease is autosomal dominant nonsyndromic hearing loss.